Koll; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koll; Hans.The latest application filed is for "method for the determination of sequence variants of polypeptides".

Company Profile

1.15.28

Koll; Hans - Schwabhausen DE
Koll; Hans - Oberroth DE
Koll; Hans - Weilheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For The Determination Of Sequence Variants Of Polypeptides App 20210371897 - Koll; Hans ; et al.	2021-12-02
A-fucosylation detection in antibodies Grant 10,352,943 - Jaeger , et al. July 16, 2	2019-07-16
Immunoglobulin Glycosylation Pattern Analysis App 20180164325 - Koll; Hans ; et al.	2018-06-14
A-fucosylation Detection In Antibodies App 20170108510 - Jaeger; Christiane ; et al.	2017-04-20
Antibodies against amyloid beta 4 with glycosylation in the variable region Grant 9,272,031 - Loetscher , et al. March 1, 2	2016-03-01
Antibodies Against Amyloid Beta 4 With Glycosylation In The Variable Region App 20150165022 - LOETSCHER; Hansruedi ; et al.	2015-06-18
Method For The Determination Of Sequence Variants Of Polypeptides App 20150064735 - Koll; Hans ; et al.	2015-03-05
Antibodies against amyloid beta 4 with glycosylation in the variable region Grant 8,906,370 - Loetscher , et al. December 9, 2	2014-12-09
A-fucosylation Detection In Antibodies App 20140302544 - Jaeger; Christiane ; et al.	2014-10-09
Method For The Determination Of Sequence Variants Of Polypeptides App 20120322093 - Koll; Hans ; et al.	2012-12-20
A-fucosylation Detection In Antibodies App 20120196310 - Jaeger; Christiane ; et al.	2012-08-02
Antibodies Against Insulin-Like Growth Factor I Receptor and Uses Thereof App 20120076778 - Koll; Hans ; et al.	2012-03-29
Immunoglobulin Glycosylation Pattern Analysis App 20110294150 - Koll; Hans ; et al.	2011-12-01
Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies App 20110117096 - BOSSENMAIER; BIRGIT ; et al.	2011-05-19
Stability Testing Of Antibodies App 20100261216 - Eser; Bianca ; et al.	2010-10-14
Erythropoietin with high specific activity Grant 7,659,373 - Burg , et al. February 9, 2	2010-02-09
Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region App 20090252724 - Loetscher; Hansruedi ; et al.	2009-10-08
Interferon-alpha polypeptides and conjugates Grant 7,541,436 - Patten , et al. June 2, 2	2009-06-02
Interferon-alpha polypeptides and conjugates Grant 7,537,755 - Patten , et al. May 26, 2	2009-05-26
Interferon-alpha polypeptides and conjugates Grant 7,531,630 - Patten , et al. May 12, 2	2009-05-12
Antibodies against insulin-like growth factor I receptor and uses thereof App 20080226635 - Koll; Hans ; et al.	2008-09-18
Interferon-alpha Polypeptides And Conjugates App 20080171363 - Patten; Phillip A. ; et al.	2008-07-17
Interferon-alpha Polypeptides And Conjugates App 20080076710 - Patten; Phillip A. ; et al.	2008-03-27
Interferon-alpha Polypeptides And Conjugates App 20080031853 - Patten; Phillip A. ; et al.	2008-02-07
Interferon-alpha polypeptides and conjugates Grant 7,318,918 - Patten , et al. January 15, 2	2008-01-15
Interferon-alpha Polypeptides And Conjugates App 20070225204 - Patten; Phillip A. ; et al.	2007-09-27
Interferon-alpha Polypeptides And Conjugates App 20070225205 - Patten; Phillip A. ; et al.	2007-09-27
Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof Grant 7,214,532 - Stern , et al. May 8, 2	2007-05-08
Preparation of erythropoietin by endogenous gene activation Grant 7,186,529 - Stern , et al. March 6, 2	2007-03-06
Interferon-alpha Polypeptides And Conjugates App 20070025966 - Patten; Phillip A. ; et al.	2007-02-01
Interferon-alpha Polypeptides And Conjugates App 20070020734 - Patten; Phillip A. ; et al.	2007-01-25
Interferon-alpha Polypeptides And Conjugates App 20070020235 - Patten; Phillip A. ; et al.	2007-01-25
Erythropoietin with high specific activity App 20050288220 - Burg, Josef ; et al.	2005-12-29
Interferon-alpha polypeptides and conjugates App 20050266465 - Patten, Phillip A. ; et al.	2005-12-01
Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof App 20040203001 - Stern, Anne ; et al.	2004-10-14
Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies App 20040106161 - Bossenmaier, Birgit ; et al.	2004-06-03
Preparation of erythropoietin by endogenous gene activation App 20030166275 - Stern, Anne ; et al.	2003-09-04
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof Grant 6,548,296 - Stern , et al. April 15, 2	2003-04-15
Preparation of erythropoietin by endogenous gene activation Grant 6,544,748 - Stern , et al. April 8, 2	2003-04-08
Preparation of erythropoietin by endogenous gene activation App 20020110913 - Stern, Anne ; et al.	2002-08-15
Production of erythropoietin by endogenous gene activation Grant 6,391,633 - Stern , et al.	2002-05-21
Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof Grant 6,346,274 - Koll , et al. February 12, 2	2002-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.